April 2012 FDA Recall Multihance by Bracco Diagnostics Inc
D-1665-2012 - Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.

This Class II drug recall was voluntarily initiated by Bracco Diagnostics Inc on April 16, 2012 for the product Multihance. The FDA reported the reason for recall as lack of assurance of sterility; product recalled due to displacement of the aluminum crimp cap during product usage.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1665-2012

Reason for Recall
Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.
Initiated
04-16-2012
Reported
09-05-2012
Quantity
4,870 Vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Bracco Diagnostics Inc
Multihance Multipack (gadobenate dimeglumine) injection, 529 mg/mL, Pharmacy Bulk Package - Not for Direct Infusion, For Intravenous Use, Rx only, a) 50 mL Single Dose Vial, b) 100 mL Single Dose Vial, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Nycomed GmbH, 78224 Singen (Germany), NDC a) 0270-5264-16, b) 0270-5264-17.

Batch or Lot Expiration Information

Lot# : a) 9J37457, 9J44058, Exp 10/12; b) 9I28973, Exp 09/12

Affected Packages Involved in this Recall